Alivus Life Sciences Declares Unaudited Q2 FY27 Results

Alivus Life Sciences Ltd announced its unaudited financial results for the second quarter and half-year ended September 30, 2026. The Board of Directors approved these results during a meeting held on October 29, 2026. The company also reported the incorporation of a wholly-owned subsidiary, Alivus Life Sciences Do Brasil Ltda., in Brazil on September 15, 2026. The financial results are presented on a standalone basis as the subsidiary has not yet commenced operations. The results have undergone a limited review by the statutory auditors.